Literature DB >> 21874752

Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization.

Tan Geok Chin1, Noraidah Masir, Hamidah Noor Hussin, Shiran Mohd Sidik, Lee Boon Cheok, Thean Yean.   

Abstract

Myeloid sarcoma (MS) is a rare extramedullary myeloid tumour. It has been reported in various sites, including lymph node, bone, skin, soft tissue, various organs and the CNS. It may precede or occur concurrently with acute myeloid leukemia. Urinary bladder involvement is extremely uncommon. We report a 70-year-old female who had MS of the urinary bladder, presented with frank and persistent hematuria associated with lower abdominal pain. She subsequently had tumour seeding in the abdominal skin via percutaneous suprapubic catheter. Tumours from both the urinary bladder and skin showed immature cells that were immunoreactive toward LCA (focal), MPO (strong), CD99 (weak) and CD117 (weak). Summary of cases in the literature is presented. The potential of its misdiagnosis and the useful markers for the diagnosis of MS are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21874752

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  3 in total

1.  Granulocytic sarcoma of bladder in an 18-mo-old child with acute myeloid leukemia.

Authors:  C G Delhi Kumar; V Thilagavathy; Thirunavukkarasu Arun Babu
Journal:  Indian J Pediatr       Date:  2014-02-25       Impact factor: 1.967

2.  Malignancies of suprapubic catheter (SPC) tracts in spinal cord injury patients: a case series and review of literature.

Authors:  Sarah Prattley; Francesca New; Melissa Davies
Journal:  Spinal Cord Ser Cases       Date:  2019-04-15

3.  Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen.

Authors:  Nikeeta Mandhan; Farah Yassine; Ke Li; Talha Badar
Journal:  Leuk Res Rep       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.